Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126334221 | 12633422 | 1 | I | 20160224 | 0 | 20160808 | 20160808 | DIR | 60.00 | YR | F | N | 115.00000 | LBS | 20160805 | N | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126334221 | 12633422 | 1 | PS | AUGMENTIN | AMOXICILLINCLAVULANATE POTASSIUM | 1 | Oral | EVERY 12 HOURS | N | D | 0 | Q12H | |||||||
| 126334221 | 12633422 | 3 | C | SYNTHROID | LEVOTHYROXINE SODIUM | 1 | 0 | ||||||||||||
| 126334221 | 12633422 | 5 | C | SIMVASTIN | SIMVASTATIN | 1 | 0 | ||||||||||||
| 126334221 | 12633422 | 7 | C | EFFEXOR | VENLAFAXINE HYDROCHLORIDE | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126334221 | 12633422 | 1 | Ear infection |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126334221 | 12633422 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126334221 | 12633422 | Asthenia | |
| 126334221 | 12633422 | Clostridium difficile infection | |
| 126334221 | 12633422 | Dysstasia | |
| 126334221 | 12633422 | Therapy non-responder |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126334221 | 12633422 | 1 | 20160224 | 20160227 | 0 |